Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Two-step versus WHO three-step analgesic ladder for cancer pain requiring step 2 analgesia
2012-001578-26Phase 3Completed
- Sponsor
- St. Olavs University Hospital
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of morphine, oxycodone and codeine in cancer pain (2 arms), sponsored by St. Olavs University Hospital. Primary endpoint: Time to achieving stable pain control. Started May 2012; status: completed.
02
Drugs
morphineoxycodonecodeine
03
Conditions
cancer pain
Beyond the preview
Go deeper on 2012-001578-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001578-26.